`nature communications, Peer-reviewed journal

While people with type 2 diabetes tend to have poorer muscle function than others, a research team at Lund University in Sweden, now has discovered that in type 2 diabetes, a specific gene is of great importance for the ability of muscle stem cells to create new mature muscle cells.The findings are published in Nature Communications."In people with type 2 diabetes, the VPS39 gene is significantly less active in the muscle cells than it is in other people, and the stem cells with less activity of the gene do not form new muscle cells to the same degree. The gene is important when muscle cells absorb sugar from the blood and build new muscle. Our study is the first ever to link this gene to type 2 diabetes," says Charlotte Ling, professor of epigenetics at Lund University who led the study.In type 2 diabetes, the ability to produce insulin is impaired, and patients have chronically elevated blood sugar. Muscles are generally worse at absorbing sugar from food, and muscle function and strength are impaired in patients with type 2 diabetes.A muscle consists of a mixture of fibre types with different properties. Throughout life, muscle tissue has the ability to form new muscle fibres. There are also immature muscle stem cells that are activated in connection with, for example, injury or exercise. In the current study, the researchers wanted to investigate whether epigenetic patterns in muscle stem cells can provide answers to why impaired muscle function occurs in type 2 diabetes.Two groups were included in the study: 14 participants with type 2 diabetes and 14 healthy people in a control group.The participants in the groups were matched by age, gender and BMI (body mass index). The researchers studied epigenetic changes in the muscle stem cells in both groups, and under exactly the same conditions, they also extracted mature muscle cells and compared them. In total, they identified 20 genes, including VPS39, whose gene expression differed between the groups in both immature muscle stem cells and mature muscle cells. The researchers also compared the epigenetic patterns of muscle cells before and after cell differentiation in both groups."Despite the fact that both groups' muscle stem cells were grown under identical conditions, we saw more than twice as many epigenetic changes in the type 2 diabetes group during the differentiation from muscle stem cell to mature muscle cells. Muscle-specific genes were not regulated normally, and epigenetics did not function in the same way in cells from people with type 2 diabetes," says Charlotte Ling."The study clearly showed that muscle stem cells that lack the function of the gene VPS39, which is lower in type 2 diabetes, also lack the ability to form new mature muscle cells. This is because muscle stem cells that lack VPS39 due to altered epigenetic mechsms cannot change their metabolism in the same way as muscle stem cells from controls -- the cells, therefore, remain immature or break down and die," says Johanna Sall Sernevi, postdoc researcher at Lund University.To confirm the findings, the researchers also used mal models with mice that had a reduced amount of the VPS39 gene, to mimic the disease. The mice subsequently had altered gene expression and reduced uptake of sugar from the blood into the muscle tissue, just like the individuals with type 2 diabetes.The comprehensive study is a collaboration between Swedish, Dsh and German researchers, who believe that the findings open up new avenues for treating type 2 diabetes."The genome, our DNA, cannot be changed, although epigenetics in effect does. With this new knowledge, it is possible to change the dysfunctional epigenetics that occur in type 2 diabetes. For example, by regulating proteins, stimulating or increasing the amount of the VPS39 gene, it would be possible to affect the muscles' ability to regenerate and absorb sugar," concludes Charlotte Ling.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

`nature CommunicationsFOLLOW

`nature communications, Latest News

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight ...

According to a new research from North Carolina State University, 3D-printable gels with improved and highly controlled properties can be created by merging micro-and nano-sized networks of the same materials harnessed from seaweed. ...

A complicated interaction between different proteins is needed for information to pass from one nerve cell to the next. A team of researchers now managed to study this process in the synaptic vesicles, which play an important role in this process. ...

An international group of collaborators led by researchers at UPMC Children's Hospital of Pittsburgh have identified a genetic cause of a rare neurological disorder marked by developmental delay and loss of coordination, or ataxia. The research was p ...

Research led by the Garvan Institute of Medical Research has for the first time mapped the unique genetic profile of the skeleton's 'master regulator' cells, known as osteocytes. ...

Researchers from the Wellcome Sanger Institute found that a specific genetic mutation, which is linked with poor prognosis in blood cancer, is involved in the development of the disease when combined with other mutations in mice and human cell lines. ...

Human decision-making depends on the flexible processing of complex information, but how the brain may adapt processing to momentary task demands has remained unclear. ...

While people with type 2 diabetes tend to have poorer muscle function than others, a research team at Lund University in Sweden, now has discovered that in type 2 diabetes, a specific gene is of great importance for the ability of muscle stem cells t ...